Logo image of XCT.CA

exactEarth Ltd (XCT.CA) Stock Fundamental Analysis

TSX:XCT - Toronto Stock Exchange - Common Stock

3.1  +0.05 (+1.64%)

Fundamental Rating

2

Taking everything into account, XCT scores 2 out of 10 in our fundamental rating. XCT was compared to 1 industry peers in the Transportation Infrastructure industry. XCT has a bad profitability rating. Also its financial health evaluation is rather negative. XCT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XCT has reported negative net income.
XCT.CA Yearly Net Income VS EBIT VS OCF VS FCFXCT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -11.2%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XCT.CA Yearly ROA, ROE, ROICXCT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 100 -100 -200 -300

1.3 Margins

Industry RankSector Rank
OM -1.24%
PM (TTM) -9.36%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XCT.CA Yearly Profit, Operating, Gross MarginsXCT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for XCT has been increased compared to 1 year ago.
Compared to 1 year ago, XCT has a worse debt to assets ratio.
XCT.CA Yearly Shares OutstandingXCT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M
XCT.CA Yearly Total Debt VS Total AssetsXCT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.50, we must say that XCT is in the distress zone and has some risk of bankruptcy.
XCT has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -0.5
ROIC/WACCN/A
WACCN/A
XCT.CA Yearly LT Debt VS Equity VS FCFXCT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 20M 40M

2.3 Liquidity

XCT has a Current Ratio of 1.58. This is a normal value and indicates that XCT is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.58 indicates that XCT should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
XCT.CA Yearly Current Assets VS Current LiabilitesXCT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

XCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.17%, which is quite impressive.
The Revenue has grown by 35.00% in the past year. This is a very strong growth!
Measured over the past years, XCT shows a decrease in Revenue. The Revenue has been decreasing by -6.37% on average per year.
EPS 1Y (TTM)69.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.27%
Revenue 1Y (TTM)35%
Revenue growth 3Y14.26%
Revenue growth 5Y-6.37%
Sales Q2Q%25.72%

3.2 Future

Based on estimates for the next years, XCT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.76% on average per year.
XCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.54% yearly.
EPS Next Y82.43%
EPS Next 2Y51.9%
EPS Next 3Y31.76%
EPS Next 5Y22.76%
Revenue Next Year32.75%
Revenue Next 2Y23.69%
Revenue Next 3Y23.39%
Revenue Next 5Y23.54%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XCT.CA Yearly Revenue VS EstimatesXCT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XCT.CA Yearly EPS VS EstimatesXCT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2020 2021 2022 2023 2024 0 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XCT. In the last year negative earnings were reported.
XCT is valuated quite expensively with a Price/Forward Earnings ratio of 43.85.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, XCT is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 43.85
XCT.CA Price Earnings VS Forward Price EarningsXCT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 356.78
XCT.CA Per share dataXCT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XCT's earnings are expected to grow with 31.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.9%
EPS Next 3Y31.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XCT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

exactEarth Ltd

TSX:XCT (12/2/2021, 7:00:00 PM)

3.1

+0.05 (+1.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryTransportation Infrastructure
Earnings (Last)N/A N/A
Earnings (Next)12-22 2021-12-22
Inst Owners12.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap154.43M
Analysts80
Price Target2.04 (-34.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 43.85
P/S 6.69
P/FCF N/A
P/OCF N/A
P/B 21.22
P/tB N/A
EV/EBITDA 356.78
EPS(TTM)-0.23
EYN/A
EPS(NY)0.07
Fwd EY2.28%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.46
BVpS0.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1.24%
PM (TTM) -9.36%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z -0.5
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.27%
EPS Next Y82.43%
EPS Next 2Y51.9%
EPS Next 3Y31.76%
EPS Next 5Y22.76%
Revenue 1Y (TTM)35%
Revenue growth 3Y14.26%
Revenue growth 5Y-6.37%
Sales Q2Q%25.72%
Revenue Next Year32.75%
Revenue Next 2Y23.69%
Revenue Next 3Y23.39%
Revenue Next 5Y23.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A